Актинический кератоз: сравнительная эффективность медикаментозной терапии

Жучков М.В., Сонин Д.Б., Тарасова М.А. Актинический кератоз: сравнительная эффективность медикаментозной терапии. Consilium Medicum. Дерматология (Прил.). 2015; 3: 32–36.

________________________________________________

Zhuchkov M.V., Sonin D.B., Tarasova M.A. Actinic keratosis: comparative effectiveness of drug therapy. Consilium Medicum. Dermatology (Suppl.). 2015; 3: 32–36.

Читать PDF

Аннотация

В исследовании приводятся данные о сравнительной клинической эффективности двух наиболее широко используемых терапевтических модальностей в терапии эритематозного актинического кератоза.

Ключевые слова: актинический кератоз, плоскоклеточная карцинома, имиквимод, диклофенак.

________________________________________________

The study provides data on the comparative clinical efficacy of the two most widely used therapeutic modality in the treatment of actinic keratoses erythematous.
Key words: actinic keratosis, squamous cell carcinoma, imiquimod, diclofenac.

Полный текст

Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.

Список литературы

________________________________________________

1. Ackerman AB, Mones JM. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 2006; 155: 9–22.
2. Quaedvlieg PJ, Tirsi E, Thissen MR, Krekels GA. Actinic keratosis. How to differentiate the good and the bad ones? Eur J Dermatol 2006; 16: 335–9.
3. Marks R, Rennie G, Selwood T. The relationship of basal cell carcinomas and squamous cell carcinomas to solar keratoses. Arch Dermatol 1988; 124: 1039–42.
4. Haute AS. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinome and precursor lesions. Guidelines. Rev Stomatol Chir Maxillofac 2010; 111: 228–37.
5. Memon AA, Tomenson JA, Bothwell J, Friedmann PS. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000; 142: 1154–9.
6. Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol 1994; 131: 455–64.
7. Harvey I, Frankel S, Marks R et al. Non-melanoma skin cancer and solar keratoses II analytical results of the South Wales Skin Cancer Study. Br J Cancer 1996; 74: 1308–12.
8. Bickers DR, Lim HW, Margolis D et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006; 55: 490–500.
9. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer 1990; 46: 356–61.
10. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: 4–7.
11. Bernard P, Dupuy A, Sasco A et al. Basal cell carcinomas and actinic keratoses seen in dermatological practice in France: a cross-sectional Survey. Dermatology 2008; 216: 194–9.
12. Martin L, Bonerandi JJ. Carcinome épidermoïde cutané (carcinome spinocellulaire): recommandations de pratique clinique pour la prise en charge diagnostique et thérapeutique. Rapport intégral. Ann Dermatol Venereol 2009; 136: S189–S242.
13. Bonerandi JJ, Beauvillain C, Caquant L et al. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol 2011; 25: 1–51.
14. Drake LA, Ceilley RI, Cornelison RL et al. Guidelines of care for actinic keratoses. Committee on Guidelines of Care. J Am Acad Dermatol 1995; 32: 95–8.
15. De Berker D, McGregor JM, Hughes BR. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol 2007; 156: 222–30.
16. Rossi R, Calzavara-Pinton PG, Giannetti A et al. Italian guidelines and therapeutic algorithm for actinic keratoses. G Ital Dermatol Venereol 2009; 144: 713–23.
17. Stockfleth E, Kerl H. Guidelines for the management of actinic keratoses. Eur J Dermatol 2006; 16: 599–606.
18. Stockfleth E, Ferrandiz C, Grob JJ et al. European Skin Academy. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 2008; 18: 651–9.
19. Lansbury L, Leonardi-Bee J, Perkins W et al. Interventions for non-metastatic squamous cell carcinoma of the skin. Cochrane Database Syst Rev 2010; CD007869.
20. Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a Queensland community. J Invest Dermatol 2000; 115: 273–7.
21. Dodson JM, DeSpain J, Hewett JE, Clark DP. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol 1991; 127: 1029–31.
22. Feldman SR, Fleischer AB Jr. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Cutis 2011; 87: 201–7.
23. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous carcinoma. Lancet 1988; 1: 795–7.
24. Katz TM, Goldberg LH, Marquez D et al. Nonablative fractional photothermolysis for facial actinic keratoses: 6 month follow-up with histologic evaluation. J Am Acad Dermatol 2011; 65: 349–56.
25. Pariser D, Loss R, Jarratt M et al. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: a randomized, double-blind, placebo-controlled study. J Am Acad Dermatol 2008; 59: 569–76.
26. Ceilley RI, Jorizzo JL. Current issues in the management of actinic keratosis. J Am Acad Dermatol 2013; 68: 28–38.
27. Marks R, Foley P, Goodman G et al. Spontaneous clearance of solar keratoses: the case for conservative management. Br J Dermatol 1986; 115: 649–55.
28. Mittelbronn MA, Mullins DL, Ramos-Caro FA, Flowers FP. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol 1998; 37: 677–81.

Авторы

М.В.Жучков*1,2, Д.Б.Сонин1,2, М.А.Тарасова1–3, Л.А.Борискина1
1. ГБУ РО Областной клинический кожно-венерологический диспансер. 390046, Россия, Рязань, ул. Спортивная, д. 9;
2. ООО Российское общество дерматовенерологов и косметологов. 107076, Россия, Москва, ул. Короленко, д. 3, стр. 6;
3. ГБОУ ВПО Рязанский государственный медицинский университет им. акад. И.П.Павлова Минздрава России. 390026, Россия, Рязань,
ул. Высоковольтная, д. 9
*misha.juchkov@gmail.com

________________________________________________

M.V.Zhuchkov*1,2, D.B.Sonin1,2, M.A.Tarasova1–3, L.A.Boriskina1
1. Ryazan State Regional Dermato-Venerological Clinic. 390046, Russian Federation, Ryazan, ul. Sportivnaia, d. 9;
2. Russian Society of Dermatovenereologists and Cosmetologists. 107076, Russian Federation, Moscow, ul. Korolenko, d. 3, str. 6;
3. I.P.Pavlov Ryazan State Medical University of the Ministry of Health of the Russian Federation. 390026, Russian Federation, Ryazan, ul. Vysokovol'tnaia, d. 9
*misha.juchkov@gmail.com

Назад к списку

Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.